Updated On: 25 February, 2026 06:57 PM IST | New Delhi | PTI
The Supreme Court sought details on the cost and availability of mandatory NAT testing in government hospitals while hearing a PIL by Sarvesham Mangalam Foundation seeking recognition of the “Right to Safe Blood” and safer transfusions for Thalassemia patients
-1772015700788_d.png)
The Supreme Court questions availability of NAT in government hospitals. File Pic
The Supreme Court on Wednesday sought more details such as costs and availability of the facility to conduct Nucleic Acid Amplification Testing (NAT) in government hospitals across the country to detect Transfusion Transmissible Infections like HIV and hepatitis.
A bench comprising Chief Justice Surya Kant and justices Joymalya Bagchi and Vipul M Pancholi asked lawyer A Velan, appearing for PIL petitioner 'Sarvesham Mangalam Foundation', to provide details as to how much cost will be incurred in conducting NAT tests and whether the facility was available in government hospitals so that poor can also avail it.